Pharmacology and Therapeutics

Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics
Usman Arshad, Henry Pertinez, Helen Box, Lee Tatham, Rajith KR Rajoli, Paul Curley, Megan Neary, Joanne Sharp, Neill J Liptrott, Anthony Valentijn, Christopher David, Steve P Rannard, Paul O'Neill, Ghaith Aljayyoussi, Shaun Pennington, Stephen A Ward, David J Back, Saye H Khoo, Patrick G Bray, Giancarlo Biagini, Andrew Owen

medRxiv 2020.04.16.20068379; doi: https://doi.org/10.1101/2020.04.16.20068379

Add to Selected Citations
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019（COVID-19）
Ming Zhong, Aijun Sun, Ting Xiao, Ge Yao, Ling Sang, Xia Zheng, Jinyan Zhang, Xuejuan Jin, Lei Xu, Wenlong Yang, Peng Wang, Kai Hu, Dingyu Zhang, Junbo Ge

medRxiv 2020.04.15.20066266; doi: https://doi.org/10.1101/2020.04.15.20066266

Add to Selected Citations
Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence
Krishna Sriram, Paul A. Insel

medRxiv 2020.03.25.20043927; doi: https://doi.org/10.1101/2020.03.25.20043927

Add to Selected Citations
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
Jing Wang, Li Yu, Kefeng Li

medRxiv 2020.04.13.20064295; doi: https://doi.org/10.1101/2020.04.13.20064295

Add to Selected Citations
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study
CHEN SHI, CONG WANG, HANXIANG WANG, CHAO YANG, FEI CAI, FANG ZENG, FANG CHENG, YIHUI LIU, TAOTAO ZHOU, BIN DENG, Israel Vlodavsky, JINPING LI, YU ZHANG

medRxiv 2020.03.28.20046144; doi: https://doi.org/10.1101/2020.03.28.20046144

Add to Selected Citations
A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
Parul Verma, Jayachandran Devaraj, Jodi L. Skiles, Tammy Sajdyk, Richard H. Ho, Raymond Hutchinson, Elizabeth Wells, Lang Li, Jamie Renbarger, Bruce Cooper, Doraiswami Ramkrishna

medRxiv 19013078; doi: https://doi.org/10.1101/19013078

Add to Selected Citations
Therapeutic Application of Chloroquine and Hydroxychloroquine in Clinical Trials for COVID-19: A systematic review
Divya RSJB Rana, Santosh Dulal

medRxiv 2020.03.22.20040964; doi: https://doi.org/10.1101/2020.03.22.20040964

Add to Selected Citations
Evaluating signals generated in a large-scale sequence symmetry analyses: macrolides and heart failure; and NSAIDs and pneumonia
Sarah-Jo Sinnott, Kueiyu J Lin, Shirley Wang, Jesper Hallas, Rishi Desai, Sebastian Schneeweiss, Joshua J Gagne

medRxiv 2020.03.19.20038596; doi: https://doi.org/10.1101/2020.03.19.20038596

Add to Selected Citations
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 Gangliosidoses, and Ataxia Telangiectasia
Taylor Fields, Marc Patterson, Tatiana Bremova, Glyn Belcher, Ian Billington, Grant C Churchill, William Davis, William Evans, Susan Flint, Antony Galione, Ulrich Granzer, Julia Greenfield, Rick Karl, Richard Kay, Dan Lewi, Toni Mathieson, Thorsten Meyer, Diana Pangonis, Frances M Platt, Lincoln Tsang, Christa Verburg, Mallory Factor, Michael Strupp

medRxiv 2020.03.11.20034256; doi: https://doi.org/10.1101/2020.03.11.20034256

Add to Selected Citations
Examination of WHO/INRUD Core Drug Use Indicators at Public Primary Healthcare Centers in Kisii County, Kenya
AGGREY ORWENYO NYABUTI, FAITH APOLOT OKALEBO, ERIC GUANTAI

medRxiv 2020.03.15.20036269; doi: https://doi.org/10.1101/2020.03.15.20036269

Add to Selected Citations

Pharmacology and Therapeutics

Pages